Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies
Feasibility of the LUM Imaging System for Detection of Peritoneal Surface Malignancies
Sponsor: Lumicell, Inc.
Listed as NCT03834272, this PHASE1/PHASE2 trial focuses on Peritoneal Metastases and remains completed. Sponsored by Lumicell, Inc., it has been updated 15 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE1/PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Dec 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
▶ Show 10 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2023 — Apr 2024 [monthly]
Recruiting PHASE1_PHASE2
Phase: NA → PHASE1_PHASE2
-
Oct 2021 — Jan 2023 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jun 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Aug 2020 [monthly]
Recruiting NA
-
Jun 2019 — Feb 2020 [monthly]
Recruiting NA
-
Apr 2019 — Jun 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Lumicell, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .